We therefore evaluated the MED15 expression in tumor-free testis and TGCT subentities by immunohistochemical staining (IHC) on a large tissue microarray (TMA) cohort in order to evaluate a possible diagnostic and therapeutic value for MED15 in TGCT. This evidence concerns the gene MED15 and neoplasm.